Overexpression of C16orf74 is involved in aggressive pancreatic cancers

Clinical outcome of pancreatic ductal adenocarcinoma (PDAC) has not been improved in the last three decades due to the lack of effective molecular-targeted drugs. To identify a novel therapeutic target for PDAC, we have performed genome-wide anamysis and found that Homo sapiens chromosome 16 open re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Nakamura, Toru, Katagiri, Toyomasa, Sato, Shoki, Kushibiki, Toshihiro, Hontani, Koji, Tsuchikawa, Takahiro, Hirano, Satoshi, Nakamura, Yusuke
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5584151/
https://ncbi.nlm.nih.gov/pubmed/28881575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10912
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados